Health Solutions

Pharmaceuticals

Overview

Pharmaceuticals overview

Rapid changes in the pharmaceutical and drug development fields require a dedicated team of experts. Our consulting experience includes applying actuarial principles to health economics challenges for both pharmaceuticals and medical devices and builds on the support of in-house health economists and clinicians. Our areas of research draw on real-world evidence and outcomes data.

INSIGHT

Milliman pharmaceuticals insight

Article

Actuarial approaches to modelling and mitigating financial uncertainty in recommending new drugs and health technologies

In collaboration with the National Institute for Health and Care Excellence (NICE) in England, we explore some alternative methodological approaches that build on the incremental cost-effectiveness ratio.

Download PDF

Presentation

Can we use insurance-based reimbursement models for novel antibiotics?

We explore how the principles of insurance can be applied to structure reimbursement models for novel antibiotics, and ultimately stimulate innovation while offering financial protection to payers.

Download PDF

Research Report

Evaluating payment models for high-cost curative therapies

A research report that evaluates alternative payment models that potentially could be instituted by healthcare payers and manufacturers to pay for high-cost curative disease therapies and prescription drugs.

Read the article

Article

Genomic testing: Cost-savings or cost-inflating for payers

The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.

Read the article

Interview

U.K.'s NICE sheds light on comparative value

The National Institute for Health and Clinical Excellence in England offers an interesting model for healthcare reform. We asked Joanne Buckle for her perspective.

Read the article

Milliman Inpatient Benchmarking Tool

Milliman's Inpatient Benchmarking Tool is designed to help public health systems like the NHS make better use of their limited resources. The tool aims to reflect an absolute standard of care of what is possible to achieve given optimal infrastructure and best practice care.

Learn more